NCT00406900Unknown不适用
Melanoma Inhibitory Activity (MIA): A Serological Marker for Metastatic Uveal Melanoma
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 560
- 试验地点
- 1
研究概览
简要总结
Uveal Melanoma is the most common primary intraocular tumor in adults. Most tumors metastasize to the liver. So far no sensitive or specific serological tumor marker is routinely used. The marker "Melanoma inhibitory activity" is a promising marker. Study hypothesis is to detect metastatic lesions in an early stage. This would increase life expectance of our patients
详细描述
Serum is taken from each melanoma patient at every follow up after signed concent. With ELISA the marker MIA is evaluated. An increase of MIA serum level will lead to search for metastasis by oncologists.
研究设计
- 研究类型
- Observational
- 观察模型
- Defined Population
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •uveal melanoma (With/without overt metastatic disease)
排除标准
- 未提供
研究者
研究点 (1)
Loading locations...
相似试验
招募中
3 期
PHP in Combination With IPI1/NIVO3 Compared to IPI3/NIVO1 Only in Patients With Uveal Melanoma Liver MetastasesUveal MelanomaLiver MetastasesNCT06519266Vastra Gotaland Region40
招募中
3 期
Adjuvant Melatonin for Uveal MelanomaUveal MelanomaUveal Melanoma, Posterior, Medium/Large SizeEye Cancer, Intraocular MelanomaNCT05502900Gustav Stalhammar100
Unknown
4 期
Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque RadiotherapyUveal MelanomaRadiation RetinopathyRadiation MaculopathyNCT00540930Shields, Shields and Associates400
招募中
不适用
Assessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal MelanomaUveal MelanomaNCT01438658Hadassah Medical Organization250
Unknown
2 期
A Study of Sorafenib in Patients With Chemonaive Metastatic Uveal MelanomaUveal MelanomaNCT01377025Prof. Dr. med. Max. E. Scheulen200